128 results
Page 3 of 7
SC TO-T
EX-99
pxedmnoovzat527r2ckz
19 Oct 20
Third party tender offer statement
6:03am
8-K
4af42n1xbif27c
20 Nov 19
Creating a Leading Biopharma Company
5:21pm
8-K
iupl0l udramt7w
8 May 19
Other Events
5:02pm
8-K
m70 4w1pn
1 May 19
Regulation FD Disclosure
5:24pm
8-K
4fagv7r7ho83oq2 ihgl
4 Apr 19
Other Events
4:24pm
425
zy2i wtdldgfsi
4 Apr 19
Business combination disclosure
4:22pm
424B3
1j8v3dp758ue12j89s
22 Feb 19
Prospectus supplement
4:31pm
8-K
EX-10.2
8bfhny1vxqen 00quvc
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
8-K
lf6knea58n yew5vfpws
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
8-K
EX-10.1
cczx h2qn2l
30 Jan 19
Entry into a Material Definitive Agreement
4:45pm
425
EX-10.2
p8f1zppgrdu 2spdcs3
30 Jan 19
Business combination disclosure
4:43pm
425
zagk7fituf
30 Jan 19
Business combination disclosure
4:43pm
425
EX-10.1
oidoapx74a5x
30 Jan 19
Business combination disclosure
4:43pm
8-K
75tg8bp
24 Jan 19
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
8:54am
8-K
EX-10.1
hht5j3ucp7znhq
22 Jan 19
Entry into a Material Definitive Agreement
4:37pm